Firm
In the second of a two-part article, Gabrielle Faure-André and Stéphanie Garçon at Santarelli unpick EPO, UPC and French case law to assess the importance of clinical development timelines in inventive step analyses
Public figures are turning to trademark protection to combat the threat of AI deepfakes and are monetising their brand through licensing deals, a trend that law firms are keen to capitalise on
Tom Melsheimer, part of a nine-partner team to join King & Spalding from Winston & Strawn, says the move reflects Texas’s appeal as a venue for high-stakes patent litigation
AI patents and dairy trademarks are at the centre of two judgments to be handed down next week
Sponsored
Sponsored
-
Sponsored by Patrinos & KilimirisMaria Kilimiris of Patrinos & Kilimiris commends the approach taken by the Administrative Trademarks Commission in assessing the similarity of marks involving figurative elements and words -
Sponsored by MaiwaldEva Ehlich and Anja Fux of Maiwald summarise an EPO board ruling relating to substances and compositions in the context of medical use claims and how it could affect applicants’ portfolio strategies
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Mohandas Konnanath of RNA Technology and IP Attorneys analyse a ruling by the High Court of Delhi concerning the use of marks for facial cleansers
-
Sponsored by Shiga International Patent OfficeMasato Iida of Shiga International Patent Office explains how the inventive step obstacle can be cleared when preparing a patent application and presents several case studies based on combination therapy inventions
-
Sponsored by Shiga International Patent OfficeHidenori Hamai of Shiga International Patent Office compares particular claim expressions at the JPO, USPTO, and EPO
-
Sponsored by Gün and PartnersBarış Kalaycı and Begüm Soydan Sayılkan of Gün and Partners explain why trademark infringers have flocked to a popular part of the Turkish coast, and suggest what should be done in response
